Mydecine Innovations Group Inc.
MYCOF
$0.0045
-$0.0006-11.77%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 360.10K | 551.10K | 453.00K | 1.26M | 592.60K |
| Depreciation & Amortization | -- | -- | -- | 0.00 | 900.00 |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.20M | 1.65M | 463.10K | 1.82M | 658.30K |
| Operating Income | -1.20M | -1.65M | -463.10K | -1.82M | -658.30K |
| Income Before Tax | -1.46M | -1.95M | -753.40K | -6.56M | -882.00K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.46M | -1.95M | -753.40K | -6.56M | -882.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.46M | -1.95M | -753.40K | -6.56M | -882.00K |
| EBIT | -1.20M | -1.65M | -463.10K | -1.82M | -658.30K |
| EBITDA | -1.20M | -1.65M | -461.20K | -1.82M | -657.40K |
| EPS Basic | -0.02 | -0.03 | -0.01 | -0.13 | -0.03 |
| Normalized Basic EPS | -0.01 | -0.02 | -0.01 | -0.05 | -0.02 |
| EPS Diluted | -0.02 | -0.03 | -0.01 | -0.13 | -0.03 |
| Normalized Diluted EPS | -0.01 | -0.02 | -0.01 | -0.05 | -0.02 |
| Average Basic Shares Outstanding | 61.76M | 61.19M | 53.80M | 49.46M | 28.75M |
| Average Diluted Shares Outstanding | 61.76M | 61.19M | 53.80M | 49.46M | 28.75M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
